source
- AstraZeneca partners with Oracle to boost clinical trial patient recruitment using AIAstraZeneca announced a collaboration with data-technology firm Oracle to apply artificial-intelligence tools to clinical-trial recruitment. The non-binding agreement will let the partners explore…
- Pfizer makes ‘business decision’ to end phase 2 trial of autoimmune drug as program’s future uncertainPfizer has called time on a phase 2 trial of its CXCR5 antibody in an autoimmune blood disorder, with the company tight-lipped on whether this is marks end of the road for the asset.Fierce Biotech · 5h ago↗ source